Tagged Articles

Low T 116 articles

Doctors warn against overprescribing of testosterone treatments

“Why are so many people taking testosterone for an unapproved use?” ask Steven Woloshin and Lisa M. Schwartz, professors of medicine at the Dartmouth Institute for Health Policy and Clinical Practices in a Washington Post opinion piece titled, “Sell a disease to sell a drug.” Woloshin and Schwartz are co-chairs of the steering committee of Preventing Overdiagnosis, an international conference that will be held in September at the National Institutes of Health. While the overprescribing of medication can be seen with many types of medications, from painkillers to antidepressants, Woloship and Schwartz’s column focuses on the overuse of testosterone replacement ... Read More

FDA approves new warning label for testosterone replacement treatments

The safety labels of prescription testosterone replacement products warning of cardiovascular risks have been updated and approved by the Food and Drug Administration (FDA). The products include gels, patches, topical solutions, nasal sprays and injections. Brand names include: Androderm AndroGel Aveed Axiron Delatestryl Fortesta Natesto Striant Testim Testosterone Gel Vogelxo The new warning is listed under Warnings and Precautions and Adverse Reactions sections, and states, “Long term clinical safety trials have not been conducted to assess the cardiovascular outcomes of testosterone replacement therapy in men. To date, epidemiologic studies and randomized controlled trials have been inconclusive for determining the risk ... Read More

Personal injury lawsuits target testosterone makers

A conference to review the progress of discovery efforts in a group of more than 1,340 lawsuits against manufacturers of testosterone treatments is scheduled for April 21, and the first case is expected to go trial in the fall of 2016. The lawsuits were consolidated in U.S. District Court in the Northern District of Illinois and target seven testosterone makers claiming the drugs caused heart attacks, strokes and other health problems. Testosterone treatments are prescription hormones that are designed to treat hypogonadism, a condition in which men do not produce enough testosterone due to injury or disease. Pharmaceutical companies have ... Read More

Editorial calls for an end to disease mongering ‘Low T’ ads

Massive increases in prescriptions for testosterone treatments, concerns about inappropriate use of the hormones, and recent warnings about elevated risks for blood clots, heart attacks, strokes and death in patients who used the products, have prompted two researchers in an editorial in the Journal of the American Geriatrics Society to call for a ban on advertisements for testosterone supplements. “A combination of direct-to-consumer product advertising (DTCPA) and lax consensus guidelines for testosterone prescribing have, over the past decade, led to 10- and 40-fold increases in testosterone prescriptions in the United States and Canada, respectively, with Internet pharmacies playing a major ... Read More

Reduced sexual activity possible cause of drop in testosterone levels

It has been a long-held belief in the medical community that when a man’s testosterone level drops, so does his interest in sex. But a new study suggests that as a man’s sex life tapers, so does the level of testosterone in his blood. “Most people in or out of medicine assume that a lowered serum testosterone may cause reduced sexual activity. But our study questions, if not fully refutes, that assumption and suggests it is the other way around,” Dr. David Handelsman, a researcher at the University of Sydney in New South Wales, Australia, told WebMD. And if this ... Read More

Misleading advertising led to boom in testosterone treatment sales

Misleading direct-to-consumer advertising fueled prescription testosterone treatment sales in the United States and put millions of men at an increased risk of cardiovascular side effects and other effects, physicians warned in an editorial published in the Journal of the American Geriatrics Society. The editorial blames pharmaceutical companies for exploiting men by pushing testosterone replacement treatments through aggressive advertising campaigns aimed directly to men. These ads promise an increased sex drive, more energy, and increased muscle mass, resulting in many men requesting the drugs from their own physicians. Testosterone products were approved by the Food and Drug Administration (FDA) to treat hyopgonadism, ... Read More

Male menopause treatments like testosterone replacement therapy could have dangerous side effects

Testosterone replacement therapy may help relieve symptoms of so-called male menopause but it may also be hazardous to your health, recent studies suggest. Testosterone treatments have been available for decades to treat a condition known as hyopgonadism, in which the body doesn’t produce enough testosterone due to injury or a defect. Testosterone deficiency, or low testosterone levels, can cause symptoms such as low sex drive due to decreased spontaneous erections, hot flushes, loss of body hair and low sperm count. Within the past decade, manufacturers of testosterone treatments, lured by the popularity of erectile dysfunction drugs like Viagra, launched media campaigns targeting ... Read More

Physician warns men to consider testosterone replacement therapy side effects

Dr. Gerald Chodak is advising men who are considering going on testosterone replacement therapy to be aware of the known side effects and the unknown side effects with the drugs. Dr. Chodak published his warning on Medscape, a web resource for physicians and health professionals. Testosterone treatments, such as AndroGel, Axiron and Testim, are FDA-approved to treat men with a condition in which an injury or disease prevents them from producing enough testosterone. This can result in symptoms such as low sex drive, muscle loss, weight gain, and fatigue. However, pharmaceutical companies that sell testosterone treatments have launched aggressive marketing campaigns in ... Read More

Women should not be treated with testosterone therapy, Endocrine Society advises

Low testosterone is not a valid diagnosis in healthy women, and most women with low amounts of the hormone should not use testosterone-replacement drugs, the Endocrine Society said in a new guideline. “Although limited research suggests testosterone therapy in menopausal women may be linked to improved sexual function, there are too many unanswered questions to justify prescribing testosterone therapy to otherwise healthy women,” guideline task force chair Dr. Margaret Wierman, of the University of Colorado, said in news release. Dr. Wierman said that in a review of past studies, women who had low testosterone levels did not exhibit any signs ... Read More

Abbott, AbbVie face varying lawsuits with AndroGel

Abbott Laboratories and AbbVie skirted racketeering claims alleging the companies made health plans pay unnecessarily for the arthritis drug Humira and the testosterone replacement AndroGel instead of less expensive generics. U.S. District Judge Robert Dow said plaintiffs New England Carpenters Health and Welfare Fund failed to show that the defendants teamed up with pharmacies and intermediaries to illegally increase sales of the drugs by offering savings cards or coupons to reduce copayments. The fund also accused Abbott and AbbVie of insurance fraud, alleging the companies instructed pharmacies to hid subsidies by processing them as secondary insurance rather than discounts. “While ... Read More